MF
XERS icon

Magnetar Financial’s Xeris Biopharma Holdings XERS Stock Holding History

Magnetar Financial’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$192K Sell
24,215
-55,087
-69% -$352K ﹤0.01% 952
2026
Q1 		$460K Buy
+79,302
New +$526K ﹤0.01% 652

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Magnetar Financial's XERS Position: Q2 2026 in Review

Magnetar Financial reduced its Xeris Biopharma Holdings (XERS) stake by 69% in Q2 2026, selling an estimated $352K and leaving 24,215 shares worth $192K. The position accounts for ﹤0.01% of the portfolio, ranked #952.

Magnetar Financial first reported a position in XERS in Q1 2026 and has held it in 2 quarters since. The position peaked at $460K in Q1 2026. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • Magnetar Financial held 24,215 shares of Xeris Biopharma Holdings worth $192K as of Q2 2026.
  • Magnetar Financial sold 55,087 Xeris Biopharma Holdings shares in Q2 2026, an estimated $352K.
  • Xeris Biopharma Holdings made up ﹤0.01% of Magnetar Financial's portfolio in Q2 2026, its #952 holding.
  • Magnetar Financial first reported a position in Xeris Biopharma Holdings in Q1 2026 and has held it in 2 quarters since.
  • Magnetar Financial's Xeris Biopharma Holdings position peaked at $460K in Q1 2026.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on Magnetar Financial's 13F filing for Q2 2026, filed 14 Aug 2026.